nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Eye disorder—Hydrocortisone—asthma	0.000268	0.000365	CcSEcCtD
Apraclonidine—Hypersensitivity—Salbutamol—asthma	0.000268	0.000364	CcSEcCtD
Apraclonidine—Pruritus—Montelukast—asthma	0.000267	0.000363	CcSEcCtD
Apraclonidine—Conjunctivitis—Dexamethasone—asthma	0.000266	0.000361	CcSEcCtD
Apraclonidine—Conjunctivitis—Betamethasone—asthma	0.000266	0.000361	CcSEcCtD
Apraclonidine—Diarrhoea—Arformoterol—asthma	0.000264	0.000358	CcSEcCtD
Apraclonidine—Diarrhoea—Formoterol—asthma	0.000264	0.000358	CcSEcCtD
Apraclonidine—Nausea—Flunisolide—asthma	0.000263	0.000357	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisolone—asthma	0.000263	0.000357	CcSEcCtD
Apraclonidine—Asthenia—Salbutamol—asthma	0.000261	0.000355	CcSEcCtD
Apraclonidine—Vomiting—Mometasone—asthma	0.000261	0.000355	CcSEcCtD
Apraclonidine—Visual impairment—Methylprednisolone—asthma	0.00026	0.000353	CcSEcCtD
Apraclonidine—Hypersensitivity—Budesonide—asthma	0.00026	0.000353	CcSEcCtD
Apraclonidine—Dermatitis—Mometasone—asthma	0.000259	0.000352	CcSEcCtD
Apraclonidine—Diarrhoea—Montelukast—asthma	0.000258	0.000351	CcSEcCtD
Apraclonidine—Pruritus—Salbutamol—asthma	0.000258	0.00035	CcSEcCtD
Apraclonidine—Headache—Mometasone—asthma	0.000257	0.00035	CcSEcCtD
Apraclonidine—Arrhythmia—Hydrocortisone—asthma	0.000257	0.000348	CcSEcCtD
Apraclonidine—Erythema—Prednisolone—asthma	0.000256	0.000348	CcSEcCtD
Apraclonidine—Dizziness—Formoterol—asthma	0.000255	0.000346	CcSEcCtD
Apraclonidine—Dizziness—Arformoterol—asthma	0.000255	0.000346	CcSEcCtD
Apraclonidine—Asthenia—Budesonide—asthma	0.000253	0.000344	CcSEcCtD
Apraclonidine—Eye disorder—Methylprednisolone—asthma	0.000252	0.000342	CcSEcCtD
Apraclonidine—Mental disorder—Hydrocortisone—asthma	0.000252	0.000342	CcSEcCtD
Apraclonidine—Erythema—Hydrocortisone—asthma	0.00025	0.00034	CcSEcCtD
Apraclonidine—Dizziness—Montelukast—asthma	0.00025	0.000339	CcSEcCtD
Apraclonidine—Bradycardia—Betamethasone—asthma	0.00025	0.000339	CcSEcCtD
Apraclonidine—Bradycardia—Dexamethasone—asthma	0.00025	0.000339	CcSEcCtD
Apraclonidine—Pruritus—Budesonide—asthma	0.00025	0.000339	CcSEcCtD
Apraclonidine—Diarrhoea—Salbutamol—asthma	0.000249	0.000338	CcSEcCtD
Apraclonidine—Haemorrhage—Dexamethasone—asthma	0.000245	0.000333	CcSEcCtD
Apraclonidine—Haemorrhage—Betamethasone—asthma	0.000245	0.000333	CcSEcCtD
Apraclonidine—Vomiting—Formoterol—asthma	0.000245	0.000333	CcSEcCtD
Apraclonidine—Vomiting—Arformoterol—asthma	0.000245	0.000333	CcSEcCtD
Apraclonidine—Angiopathy—Methylprednisolone—asthma	0.000245	0.000332	CcSEcCtD
Apraclonidine—Nausea—Mometasone—asthma	0.000244	0.000332	CcSEcCtD
Apraclonidine—Mediastinal disorder—Methylprednisolone—asthma	0.000243	0.00033	CcSEcCtD
Apraclonidine—Dermatitis—Formoterol—asthma	0.000243	0.00033	CcSEcCtD
Apraclonidine—Dermatitis—Arformoterol—asthma	0.000243	0.00033	CcSEcCtD
Apraclonidine—Headache—Arformoterol—asthma	0.000242	0.000328	CcSEcCtD
Apraclonidine—Headache—Formoterol—asthma	0.000242	0.000328	CcSEcCtD
Apraclonidine—Arrhythmia—Triamcinolone—asthma	0.000242	0.000328	CcSEcCtD
Apraclonidine—Diarrhoea—Budesonide—asthma	0.000241	0.000328	CcSEcCtD
Apraclonidine—Vision blurred—Prednisolone—asthma	0.000241	0.000328	CcSEcCtD
Apraclonidine—Arrhythmia—Methylprednisolone—asthma	0.000241	0.000327	CcSEcCtD
Apraclonidine—Dizziness—Salbutamol—asthma	0.000241	0.000327	CcSEcCtD
Apraclonidine—Vomiting—Montelukast—asthma	0.00024	0.000326	CcSEcCtD
Apraclonidine—Dermatitis—Montelukast—asthma	0.000238	0.000323	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisolone—asthma	0.000237	0.000323	CcSEcCtD
Apraclonidine—Headache—Montelukast—asthma	0.000237	0.000321	CcSEcCtD
Apraclonidine—Visual impairment—Dexamethasone—asthma	0.000236	0.000321	CcSEcCtD
Apraclonidine—Visual impairment—Betamethasone—asthma	0.000236	0.000321	CcSEcCtD
Apraclonidine—Mental disorder—Methylprednisolone—asthma	0.000236	0.000321	CcSEcCtD
Apraclonidine—Erythema—Triamcinolone—asthma	0.000235	0.00032	CcSEcCtD
Apraclonidine—Erythema—Methylprednisolone—asthma	0.000235	0.000319	CcSEcCtD
Apraclonidine—Dizziness—Budesonide—asthma	0.000233	0.000317	CcSEcCtD
Apraclonidine—Ill-defined disorder—Hydrocortisone—asthma	0.000232	0.000315	CcSEcCtD
Apraclonidine—Vomiting—Salbutamol—asthma	0.000232	0.000315	CcSEcCtD
Apraclonidine—Malaise—Prednisolone—asthma	0.000231	0.000314	CcSEcCtD
Apraclonidine—Dysgeusia—Triamcinolone—asthma	0.00023	0.000313	CcSEcCtD
Apraclonidine—Syncope—Prednisolone—asthma	0.00023	0.000312	CcSEcCtD
Apraclonidine—Dermatitis—Salbutamol—asthma	0.000229	0.000312	CcSEcCtD
Apraclonidine—Eye disorder—Dexamethasone—asthma	0.000229	0.000311	CcSEcCtD
Apraclonidine—Eye disorder—Betamethasone—asthma	0.000229	0.000311	CcSEcCtD
Apraclonidine—Nausea—Arformoterol—asthma	0.000229	0.000311	CcSEcCtD
Apraclonidine—Nausea—Formoterol—asthma	0.000229	0.000311	CcSEcCtD
Apraclonidine—Headache—Salbutamol—asthma	0.000228	0.00031	CcSEcCtD
Apraclonidine—Malaise—Hydrocortisone—asthma	0.000225	0.000306	CcSEcCtD
Apraclonidine—Nausea—Montelukast—asthma	0.000224	0.000305	CcSEcCtD
Apraclonidine—Vomiting—Budesonide—asthma	0.000224	0.000305	CcSEcCtD
Apraclonidine—Syncope—Hydrocortisone—asthma	0.000224	0.000305	CcSEcCtD
Apraclonidine—Angiopathy—Dexamethasone—asthma	0.000223	0.000302	CcSEcCtD
Apraclonidine—Angiopathy—Betamethasone—asthma	0.000223	0.000302	CcSEcCtD
Apraclonidine—Dermatitis—Budesonide—asthma	0.000222	0.000302	CcSEcCtD
Apraclonidine—Headache—Budesonide—asthma	0.000221	0.0003	CcSEcCtD
Apraclonidine—Arrhythmia—Betamethasone—asthma	0.000219	0.000298	CcSEcCtD
Apraclonidine—Arrhythmia—Dexamethasone—asthma	0.000219	0.000298	CcSEcCtD
Apraclonidine—Ill-defined disorder—Triamcinolone—asthma	0.000218	0.000297	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methylprednisolone—asthma	0.000218	0.000296	CcSEcCtD
Apraclonidine—Bradycardia—Prednisone—asthma	0.000217	0.000295	CcSEcCtD
Apraclonidine—Nausea—Salbutamol—asthma	0.000216	0.000294	CcSEcCtD
Apraclonidine—Discomfort—Prednisolone—asthma	0.000215	0.000292	CcSEcCtD
Apraclonidine—Haemorrhage—Prednisone—asthma	0.000214	0.00029	CcSEcCtD
Apraclonidine—Erythema—Betamethasone—asthma	0.000214	0.00029	CcSEcCtD
Apraclonidine—Erythema—Dexamethasone—asthma	0.000214	0.00029	CcSEcCtD
Apraclonidine—Myalgia—Hydrocortisone—asthma	0.000213	0.000289	CcSEcCtD
Apraclonidine—Malaise—Triamcinolone—asthma	0.000212	0.000288	CcSEcCtD
Apraclonidine—Malaise—Methylprednisolone—asthma	0.000212	0.000288	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000211	0.000287	CcSEcCtD
Apraclonidine—Syncope—Triamcinolone—asthma	0.000211	0.000287	CcSEcCtD
Apraclonidine—Syncope—Methylprednisolone—asthma	0.000211	0.000286	CcSEcCtD
Apraclonidine—Discomfort—Hydrocortisone—asthma	0.00021	0.000286	CcSEcCtD
Apraclonidine—Nausea—Budesonide—asthma	0.00021	0.000285	CcSEcCtD
Apraclonidine—Oedema—Prednisolone—asthma	0.000209	0.000284	CcSEcCtD
Apraclonidine—Oedema—Hydrocortisone—asthma	0.000204	0.000277	CcSEcCtD
Apraclonidine—Infection—Hydrocortisone—asthma	0.000203	0.000275	CcSEcCtD
Apraclonidine—Myalgia—Triamcinolone—asthma	0.0002	0.000272	CcSEcCtD
Apraclonidine—Nervous system disorder—Hydrocortisone—asthma	0.0002	0.000272	CcSEcCtD
Apraclonidine—Myalgia—Methylprednisolone—asthma	0.0002	0.000272	CcSEcCtD
Apraclonidine—Eye disorder—Prednisone—asthma	0.0002	0.000271	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000199	0.00027	CcSEcCtD
Apraclonidine—Skin disorder—Hydrocortisone—asthma	0.000198	0.000269	CcSEcCtD
Apraclonidine—Ill-defined disorder—Betamethasone—asthma	0.000198	0.000269	CcSEcCtD
Apraclonidine—Ill-defined disorder—Dexamethasone—asthma	0.000198	0.000269	CcSEcCtD
Apraclonidine—Discomfort—Triamcinolone—asthma	0.000198	0.000269	CcSEcCtD
Apraclonidine—Discomfort—Methylprednisolone—asthma	0.000198	0.000268	CcSEcCtD
Apraclonidine—Dry mouth—Triamcinolone—asthma	0.000196	0.000266	CcSEcCtD
Apraclonidine—Angiopathy—Prednisone—asthma	0.000194	0.000263	CcSEcCtD
Apraclonidine—Malaise—Betamethasone—asthma	0.000193	0.000262	CcSEcCtD
Apraclonidine—Malaise—Dexamethasone—asthma	0.000193	0.000262	CcSEcCtD
Apraclonidine—Oedema—Triamcinolone—asthma	0.000192	0.000261	CcSEcCtD
Apraclonidine—Syncope—Betamethasone—asthma	0.000192	0.00026	CcSEcCtD
Apraclonidine—Syncope—Dexamethasone—asthma	0.000192	0.00026	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisone—asthma	0.000191	0.000259	CcSEcCtD
Apraclonidine—Infection—Triamcinolone—asthma	0.000191	0.000259	CcSEcCtD
Apraclonidine—Infection—Methylprednisolone—asthma	0.00019	0.000259	CcSEcCtD
Apraclonidine—Insomnia—Prednisolone—asthma	0.000189	0.000257	CcSEcCtD
Apraclonidine—Nervous system disorder—Methylprednisolone—asthma	0.000188	0.000255	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisolone—asthma	0.000188	0.000255	CcSEcCtD
Apraclonidine—Mental disorder—Prednisone—asthma	0.000187	0.000254	CcSEcCtD
Apraclonidine—Skin disorder—Methylprednisolone—asthma	0.000186	0.000253	CcSEcCtD
Apraclonidine—Erythema—Prednisone—asthma	0.000186	0.000253	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Hydrocortisone—asthma	0.000186	0.000252	CcSEcCtD
Apraclonidine—Insomnia—Hydrocortisone—asthma	0.000185	0.000251	CcSEcCtD
Apraclonidine—Paraesthesia—Hydrocortisone—asthma	0.000183	0.000249	CcSEcCtD
Apraclonidine—Myalgia—Betamethasone—asthma	0.000182	0.000247	CcSEcCtD
Apraclonidine—Myalgia—Dexamethasone—asthma	0.000182	0.000247	CcSEcCtD
Apraclonidine—Discomfort—Betamethasone—asthma	0.00018	0.000244	CcSEcCtD
Apraclonidine—Discomfort—Dexamethasone—asthma	0.00018	0.000244	CcSEcCtD
Apraclonidine—Pain—Prednisolone—asthma	0.000179	0.000243	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Hydrocortisone—asthma	0.000176	0.000239	CcSEcCtD
Apraclonidine—Fatigue—Hydrocortisone—asthma	0.000176	0.000239	CcSEcCtD
Apraclonidine—Vision blurred—Prednisone—asthma	0.000175	0.000238	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Triamcinolone—asthma	0.000175	0.000238	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000175	0.000237	CcSEcCtD
Apraclonidine—Pain—Hydrocortisone—asthma	0.000174	0.000237	CcSEcCtD
Apraclonidine—Oedema—Dexamethasone—asthma	0.000174	0.000237	CcSEcCtD
Apraclonidine—Oedema—Betamethasone—asthma	0.000174	0.000237	CcSEcCtD
Apraclonidine—Insomnia—Triamcinolone—asthma	0.000174	0.000236	CcSEcCtD
Apraclonidine—Insomnia—Methylprednisolone—asthma	0.000173	0.000235	CcSEcCtD
Apraclonidine—Infection—Betamethasone—asthma	0.000173	0.000235	CcSEcCtD
Apraclonidine—Infection—Dexamethasone—asthma	0.000173	0.000235	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisone—asthma	0.000173	0.000234	CcSEcCtD
Apraclonidine—Paraesthesia—Triamcinolone—asthma	0.000172	0.000234	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisolone—asthma	0.000172	0.000234	CcSEcCtD
Apraclonidine—Paraesthesia—Methylprednisolone—asthma	0.000172	0.000234	CcSEcCtD
Apraclonidine—Dyspnoea—Triamcinolone—asthma	0.000171	0.000233	CcSEcCtD
Apraclonidine—Nervous system disorder—Dexamethasone—asthma	0.000171	0.000232	CcSEcCtD
Apraclonidine—Nervous system disorder—Betamethasone—asthma	0.000171	0.000232	CcSEcCtD
Apraclonidine—Feeling abnormal—Hydrocortisone—asthma	0.000168	0.000228	CcSEcCtD
Apraclonidine—Malaise—Prednisone—asthma	0.000168	0.000228	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Hydrocortisone—asthma	0.000167	0.000227	CcSEcCtD
Apraclonidine—Syncope—Prednisone—asthma	0.000167	0.000227	CcSEcCtD
Apraclonidine—Fatigue—Triamcinolone—asthma	0.000166	0.000225	CcSEcCtD
Apraclonidine—Fatigue—Methylprednisolone—asthma	0.000165	0.000224	CcSEcCtD
Apraclonidine—Pain—Triamcinolone—asthma	0.000164	0.000223	CcSEcCtD
Apraclonidine—Abdominal pain—Hydrocortisone—asthma	0.000161	0.000219	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dexamethasone—asthma	0.000159	0.000216	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Betamethasone—asthma	0.000159	0.000216	CcSEcCtD
Apraclonidine—Myalgia—Prednisone—asthma	0.000158	0.000215	CcSEcCtD
Apraclonidine—Feeling abnormal—Triamcinolone—asthma	0.000158	0.000215	CcSEcCtD
Apraclonidine—Feeling abnormal—Methylprednisolone—asthma	0.000158	0.000215	CcSEcCtD
Apraclonidine—Insomnia—Betamethasone—asthma	0.000158	0.000214	CcSEcCtD
Apraclonidine—Insomnia—Dexamethasone—asthma	0.000158	0.000214	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000157	0.000214	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methylprednisolone—asthma	0.000157	0.000213	CcSEcCtD
Apraclonidine—Paraesthesia—Betamethasone—asthma	0.000156	0.000213	CcSEcCtD
Apraclonidine—Paraesthesia—Dexamethasone—asthma	0.000156	0.000213	CcSEcCtD
Apraclonidine—Discomfort—Prednisone—asthma	0.000156	0.000213	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisolone—asthma	0.000154	0.000209	CcSEcCtD
Apraclonidine—Oedema—Prednisone—asthma	0.000152	0.000206	CcSEcCtD
Apraclonidine—Abdominal pain—Methylprednisolone—asthma	0.000152	0.000206	CcSEcCtD
Apraclonidine—Infection—Prednisone—asthma	0.000151	0.000205	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Betamethasone—asthma	0.00015	0.000204	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Dexamethasone—asthma	0.00015	0.000204	CcSEcCtD
Apraclonidine—Hypersensitivity—Hydrocortisone—asthma	0.00015	0.000204	CcSEcCtD
Apraclonidine—Fatigue—Dexamethasone—asthma	0.00015	0.000204	CcSEcCtD
Apraclonidine—Fatigue—Betamethasone—asthma	0.00015	0.000204	CcSEcCtD
Apraclonidine—Pain—Betamethasone—asthma	0.000149	0.000202	CcSEcCtD
Apraclonidine—Pain—Dexamethasone—asthma	0.000149	0.000202	CcSEcCtD
Apraclonidine—Nervous system disorder—Prednisone—asthma	0.000149	0.000202	CcSEcCtD
Apraclonidine—Skin disorder—Prednisone—asthma	0.000147	0.0002	CcSEcCtD
Apraclonidine—Asthenia—Hydrocortisone—asthma	0.000146	0.000199	CcSEcCtD
Apraclonidine—Pruritus—Hydrocortisone—asthma	0.000144	0.000196	CcSEcCtD
Apraclonidine—Feeling abnormal—Betamethasone—asthma	0.000144	0.000195	CcSEcCtD
Apraclonidine—Feeling abnormal—Dexamethasone—asthma	0.000144	0.000195	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Betamethasone—asthma	0.000143	0.000194	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dexamethasone—asthma	0.000143	0.000194	CcSEcCtD
Apraclonidine—Hypersensitivity—Triamcinolone—asthma	0.000142	0.000192	CcSEcCtD
Apraclonidine—Hypersensitivity—Methylprednisolone—asthma	0.000141	0.000192	CcSEcCtD
Apraclonidine—Diarrhoea—Hydrocortisone—asthma	0.00014	0.00019	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Prednisone—asthma	0.000138	0.000188	CcSEcCtD
Apraclonidine—Dizziness—Prednisolone—asthma	0.000138	0.000188	CcSEcCtD
Apraclonidine—Asthenia—Triamcinolone—asthma	0.000138	0.000187	CcSEcCtD
Apraclonidine—Abdominal pain—Dexamethasone—asthma	0.000138	0.000187	CcSEcCtD
Apraclonidine—Abdominal pain—Betamethasone—asthma	0.000138	0.000187	CcSEcCtD
Apraclonidine—Asthenia—Methylprednisolone—asthma	0.000138	0.000187	CcSEcCtD
Apraclonidine—Insomnia—Prednisone—asthma	0.000137	0.000186	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisone—asthma	0.000136	0.000185	CcSEcCtD
Apraclonidine—Pruritus—Triamcinolone—asthma	0.000136	0.000185	CcSEcCtD
Apraclonidine—Pruritus—Methylprednisolone—asthma	0.000136	0.000184	CcSEcCtD
Apraclonidine—Dizziness—Hydrocortisone—asthma	0.000135	0.000183	CcSEcCtD
Apraclonidine—Dermatitis—Prednisolone—asthma	0.000132	0.000179	CcSEcCtD
Apraclonidine—Diarrhoea—Methylprednisolone—asthma	0.000131	0.000178	CcSEcCtD
Apraclonidine—Fatigue—Prednisone—asthma	0.000131	0.000178	CcSEcCtD
Apraclonidine—Headache—Prednisolone—asthma	0.000131	0.000178	CcSEcCtD
Apraclonidine—Constipation—Prednisone—asthma	0.00013	0.000176	CcSEcCtD
Apraclonidine—Vomiting—Hydrocortisone—asthma	0.00013	0.000176	CcSEcCtD
Apraclonidine—Dermatitis—Hydrocortisone—asthma	0.000129	0.000175	CcSEcCtD
Apraclonidine—Headache—Hydrocortisone—asthma	0.000128	0.000174	CcSEcCtD
Apraclonidine—Dizziness—Triamcinolone—asthma	0.000127	0.000173	CcSEcCtD
Apraclonidine—Dizziness—Methylprednisolone—asthma	0.000127	0.000172	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisone—asthma	0.000125	0.00017	CcSEcCtD
Apraclonidine—Asthenia—Dexamethasone—asthma	0.000125	0.00017	CcSEcCtD
Apraclonidine—Asthenia—Betamethasone—asthma	0.000125	0.00017	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Prednisone—asthma	0.000124	0.000169	CcSEcCtD
Apraclonidine—Nausea—Prednisolone—asthma	0.000124	0.000169	CcSEcCtD
Apraclonidine—Pruritus—Dexamethasone—asthma	0.000123	0.000168	CcSEcCtD
Apraclonidine—Pruritus—Betamethasone—asthma	0.000123	0.000168	CcSEcCtD
Apraclonidine—Vomiting—Triamcinolone—asthma	0.000122	0.000166	CcSEcCtD
Apraclonidine—Vomiting—Methylprednisolone—asthma	0.000122	0.000166	CcSEcCtD
Apraclonidine—Nausea—Hydrocortisone—asthma	0.000121	0.000165	CcSEcCtD
Apraclonidine—Dermatitis—Triamcinolone—asthma	0.000121	0.000164	CcSEcCtD
Apraclonidine—Dermatitis—Methylprednisolone—asthma	0.000121	0.000164	CcSEcCtD
Apraclonidine—Headache—Triamcinolone—asthma	0.00012	0.000163	CcSEcCtD
Apraclonidine—Headache—Methylprednisolone—asthma	0.00012	0.000163	CcSEcCtD
Apraclonidine—Abdominal pain—Prednisone—asthma	0.00012	0.000163	CcSEcCtD
Apraclonidine—Diarrhoea—Betamethasone—asthma	0.000119	0.000162	CcSEcCtD
Apraclonidine—Diarrhoea—Dexamethasone—asthma	0.000119	0.000162	CcSEcCtD
Apraclonidine—Dizziness—Dexamethasone—asthma	0.000115	0.000157	CcSEcCtD
Apraclonidine—Dizziness—Betamethasone—asthma	0.000115	0.000157	CcSEcCtD
Apraclonidine—Nausea—Triamcinolone—asthma	0.000114	0.000155	CcSEcCtD
Apraclonidine—Nausea—Methylprednisolone—asthma	0.000114	0.000155	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisone—asthma	0.000112	0.000152	CcSEcCtD
Apraclonidine—Vomiting—Dexamethasone—asthma	0.000111	0.000151	CcSEcCtD
Apraclonidine—Vomiting—Betamethasone—asthma	0.000111	0.000151	CcSEcCtD
Apraclonidine—Dermatitis—Betamethasone—asthma	0.00011	0.000149	CcSEcCtD
Apraclonidine—Dermatitis—Dexamethasone—asthma	0.00011	0.000149	CcSEcCtD
Apraclonidine—Headache—Dexamethasone—asthma	0.000109	0.000148	CcSEcCtD
Apraclonidine—Headache—Betamethasone—asthma	0.000109	0.000148	CcSEcCtD
Apraclonidine—Asthenia—Prednisone—asthma	0.000109	0.000148	CcSEcCtD
Apraclonidine—Pruritus—Prednisone—asthma	0.000107	0.000146	CcSEcCtD
Apraclonidine—Diarrhoea—Prednisone—asthma	0.000104	0.000141	CcSEcCtD
Apraclonidine—Nausea—Betamethasone—asthma	0.000104	0.000141	CcSEcCtD
Apraclonidine—Nausea—Dexamethasone—asthma	0.000104	0.000141	CcSEcCtD
Apraclonidine—Dizziness—Prednisone—asthma	0.0001	0.000136	CcSEcCtD
Apraclonidine—Vomiting—Prednisone—asthma	9.65e-05	0.000131	CcSEcCtD
Apraclonidine—Dermatitis—Prednisone—asthma	9.56e-05	0.00013	CcSEcCtD
Apraclonidine—Headache—Prednisone—asthma	9.51e-05	0.000129	CcSEcCtD
Apraclonidine—Nausea—Prednisone—asthma	9.02e-05	0.000122	CcSEcCtD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2RA—asthma	5.15e-05	0.000195	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR3—asthma	5.12e-05	0.000194	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCR5—asthma	5.11e-05	0.000194	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—C3—asthma	5.11e-05	0.000194	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—BDKRB2—asthma	5.04e-05	0.000191	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2RA—asthma	5.04e-05	0.000191	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—POMC—asthma	5.03e-05	0.000191	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—VEGFA—asthma	5e-05	0.00019	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—C3—asthma	4.99e-05	0.000189	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NPY—asthma	4.99e-05	0.000189	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GSTP1—asthma	4.97e-05	0.000188	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EDNRB—asthma	4.96e-05	0.000188	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—TGFB1—asthma	4.91e-05	0.000186	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TAC1—asthma	4.91e-05	0.000186	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NPS—asthma	4.91e-05	0.000186	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—KNG1—asthma	4.91e-05	0.000186	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—HMOX1—asthma	4.9e-05	0.000186	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—POMC—asthma	4.89e-05	0.000185	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ITPR1—asthma	4.89e-05	0.000185	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—AGTR1—asthma	4.88e-05	0.000185	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADCY2—asthma	4.88e-05	0.000185	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL3—asthma	4.86e-05	0.000184	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NQO1—asthma	4.84e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CAT—asthma	4.84e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PPP2CA—asthma	4.84e-05	0.000183	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCR3—asthma	4.82e-05	0.000182	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AGTR2—asthma	4.81e-05	0.000182	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCL2—asthma	4.79e-05	0.000181	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL2—asthma	4.78e-05	0.000181	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6R—asthma	4.77e-05	0.000181	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL10—asthma	4.77e-05	0.000181	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCR5—asthma	4.75e-05	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—RHOA—asthma	4.75e-05	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ADCY2—asthma	4.74e-05	0.000179	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2RA—asthma	4.68e-05	0.000177	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NTRK1—asthma	4.68e-05	0.000177	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CYBA—asthma	4.66e-05	0.000177	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—C3—asthma	4.64e-05	0.000176	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADRB2—asthma	4.63e-05	0.000175	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EDNRB—asthma	4.61e-05	0.000175	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TGFB1—asthma	4.59e-05	0.000174	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—KNG1—asthma	4.58e-05	0.000174	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—POMC—asthma	4.57e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PLA2G4A—asthma	4.57e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GSTM1—asthma	4.57e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PARP1—asthma	4.57e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL5—asthma	4.57e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TAC1—asthma	4.56e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NPS—asthma	4.56e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—AGTR1—asthma	4.56e-05	0.000173	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCR3—asthma	4.47e-05	0.00017	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCL2—asthma	4.47e-05	0.000169	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6R—asthma	4.46e-05	0.000169	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL10—asthma	4.45e-05	0.000169	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—RHOA—asthma	4.43e-05	0.000168	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—BDKRB2—asthma	4.4e-05	0.000167	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—POMC—asthma	4.4e-05	0.000167	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ITPR1—asthma	4.38e-05	0.000166	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NTRK1—asthma	4.37e-05	0.000166	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CYBA—asthma	4.33e-05	0.000164	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADRB2—asthma	4.32e-05	0.000164	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—RHOA—asthma	4.31e-05	0.000163	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADCY2—asthma	4.26e-05	0.000162	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL3—asthma	4.25e-05	0.000161	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PARP1—asthma	4.24e-05	0.000161	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL5—asthma	4.24e-05	0.000161	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PPP2CA—asthma	4.21e-05	0.000159	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CD86—asthma	4.17e-05	0.000158	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCL8—asthma	4.17e-05	0.000158	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EDN1—asthma	4.14e-05	0.000157	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL5—asthma	4.1e-05	0.000155	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—BDKRB2—asthma	4.09e-05	0.000155	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ITPR1—asthma	4.09e-05	0.000155	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PLA2G4A—asthma	4.09e-05	0.000155	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—POMC—asthma	4.09e-05	0.000155	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—VEGFA—asthma	4.06e-05	0.000154	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CSF2—asthma	4.04e-05	0.000153	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GSTP1—asthma	4.04e-05	0.000153	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—RHOA—asthma	4.03e-05	0.000153	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—KNG1—asthma	4.01e-05	0.000152	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—POMC—asthma	3.99e-05	0.000151	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—AGTR1—asthma	3.98e-05	0.000151	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL2—asthma	3.98e-05	0.000151	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—HMOX1—asthma	3.98e-05	0.000151	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ITPR1—asthma	3.97e-05	0.000151	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADCY2—asthma	3.96e-05	0.00015	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL3—asthma	3.95e-05	0.00015	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SMAD3—asthma	3.93e-05	0.000149	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CAT—asthma	3.93e-05	0.000149	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCL2—asthma	3.91e-05	0.000148	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6R—asthma	3.9e-05	0.000148	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CD86—asthma	3.89e-05	0.000148	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL10—asthma	3.89e-05	0.000148	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL8—asthma	3.89e-05	0.000147	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—RHOA—asthma	3.88e-05	0.000147	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EDN1—asthma	3.86e-05	0.000146	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL5—asthma	3.83e-05	0.000145	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NTRK1—asthma	3.82e-05	0.000145	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PLA2G4A—asthma	3.82e-05	0.000145	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL8—asthma	3.78e-05	0.000143	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADRB2—asthma	3.78e-05	0.000143	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CSF2—asthma	3.78e-05	0.000143	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PPP2CA—asthma	3.76e-05	0.000143	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TGFB1—asthma	3.73e-05	0.000141	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—KNG1—asthma	3.72e-05	0.000141	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2—asthma	3.72e-05	0.000141	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—POMC—asthma	3.71e-05	0.000141	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PLA2G4A—asthma	3.71e-05	0.000141	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GSTM1—asthma	3.71e-05	0.000141	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AGTR1—asthma	3.7e-05	0.00014	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCR5—asthma	3.7e-05	0.00014	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SMAD3—asthma	3.68e-05	0.000139	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2RA—asthma	3.64e-05	0.000138	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCL2—asthma	3.63e-05	0.000138	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6R—asthma	3.62e-05	0.000137	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL10—asthma	3.62e-05	0.000137	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2—asthma	3.62e-05	0.000137	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—C3—asthma	3.61e-05	0.000137	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—RHOA—asthma	3.6e-05	0.000136	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ITPR1—asthma	3.57e-05	0.000135	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NTRK1—asthma	3.55e-05	0.000134	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL8—asthma	3.53e-05	0.000134	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—RHOA—asthma	3.52e-05	0.000133	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PPP2CA—asthma	3.52e-05	0.000133	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PDGFB—asthma	3.52e-05	0.000133	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADRB2—asthma	3.51e-05	0.000133	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCR5—asthma	3.45e-05	0.000131	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PPP2CA—asthma	3.42e-05	0.000129	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CD86—asthma	3.4e-05	0.000129	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2RA—asthma	3.4e-05	0.000129	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL8—asthma	3.4e-05	0.000129	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2—asthma	3.38e-05	0.000128	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EDN1—asthma	3.38e-05	0.000128	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—C3—asthma	3.37e-05	0.000128	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—LEP—asthma	3.36e-05	0.000127	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL5—asthma	3.35e-05	0.000127	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PLA2G4A—asthma	3.34e-05	0.000126	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ITPR1—asthma	3.32e-05	0.000126	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CSF2—asthma	3.3e-05	0.000125	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PDGFB—asthma	3.28e-05	0.000124	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—RHOA—asthma	3.27e-05	0.000124	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2—asthma	3.25e-05	0.000123	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—POMC—asthma	3.23e-05	0.000122	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SMAD3—asthma	3.21e-05	0.000122	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FN1—asthma	3.17e-05	0.00012	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CD86—asthma	3.16e-05	0.00012	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL8—asthma	3.16e-05	0.00012	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—LEP—asthma	3.14e-05	0.000119	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EDN1—asthma	3.14e-05	0.000119	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL5—asthma	3.11e-05	0.000118	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PLA2G4A—asthma	3.1e-05	0.000118	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL8—asthma	3.09e-05	0.000117	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PPP2CA—asthma	3.07e-05	0.000116	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CSF2—asthma	3.07e-05	0.000116	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2—asthma	3.02e-05	0.000114	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR5—asthma	3.02e-05	0.000114	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SMAD3—asthma	2.99e-05	0.000113	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2RA—asthma	2.98e-05	0.000113	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FN1—asthma	2.96e-05	0.000112	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2—asthma	2.95e-05	0.000112	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—C3—asthma	2.95e-05	0.000112	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ALB—asthma	2.94e-05	0.000112	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—POMC—asthma	2.89e-05	0.000109	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PDGFB—asthma	2.87e-05	0.000109	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL8—asthma	2.87e-05	0.000109	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PPP2CA—asthma	2.86e-05	0.000108	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL2—asthma	2.83e-05	0.000107	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6R—asthma	2.82e-05	0.000107	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—NOS3—asthma	2.81e-05	0.000107	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR5—asthma	2.8e-05	0.000106	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—EGFR—asthma	2.77e-05	0.000105	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2RA—asthma	2.76e-05	0.000105	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—LEP—asthma	2.75e-05	0.000104	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2—asthma	2.74e-05	0.000104	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—C3—asthma	2.74e-05	0.000104	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—POMC—asthma	2.7e-05	0.000102	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PDGFB—asthma	2.67e-05	0.000101	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL2—asthma	2.64e-05	0.0001	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SERPINE1—asthma	2.64e-05	0.0001	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6R—asthma	2.63e-05	9.98e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—POMC—asthma	2.62e-05	9.93e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FN1—asthma	2.59e-05	9.81e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—EGFR—asthma	2.58e-05	9.79e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTGS2—asthma	2.57e-05	9.76e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—LEP—asthma	2.55e-05	9.67e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RHOA—asthma	2.55e-05	9.65e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOS3—asthma	2.52e-05	9.55e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SERPINE1—asthma	2.47e-05	9.34e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FN1—asthma	2.41e-05	9.12e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ALB—asthma	2.39e-05	9.06e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RHOA—asthma	2.38e-05	9.01e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—POMC—asthma	2.36e-05	8.94e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOS3—asthma	2.35e-05	8.92e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL2—asthma	2.31e-05	8.75e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6R—asthma	2.3e-05	8.72e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NOS3—asthma	2.29e-05	8.66e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—EGFR—asthma	2.26e-05	8.56e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTEN—asthma	2.25e-05	8.51e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL8—asthma	2.23e-05	8.47e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—POMC—asthma	2.19e-05	8.31e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SERPINE1—asthma	2.16e-05	8.17e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL2—asthma	2.14e-05	8.13e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6R—asthma	2.14e-05	8.1e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2—asthma	2.14e-05	8.09e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—asthma	2.13e-05	8.05e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—EGFR—asthma	2.1e-05	7.95e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTGS2—asthma	2.09e-05	7.92e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL8—asthma	2.09e-05	7.91e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RHOA—asthma	2.08e-05	7.88e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOS3—asthma	2.06e-05	7.8e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MMP9—asthma	2.02e-05	7.66e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PTEN—asthma	2.01e-05	7.62e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SERPINE1—asthma	2e-05	7.59e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2—asthma	2e-05	7.56e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—asthma	1.99e-05	7.52e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RHOA—asthma	1.93e-05	7.32e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOS3—asthma	1.91e-05	7.24e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MMP9—asthma	1.89e-05	7.16e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PTEN—asthma	1.88e-05	7.11e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL8—asthma	1.83e-05	6.92e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTEN—asthma	1.82e-05	6.91e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—VEGFA—asthma	1.82e-05	6.88e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—STAT3—asthma	1.8e-05	6.81e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2—asthma	1.74e-05	6.61e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—asthma	1.74e-05	6.58e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL8—asthma	1.7e-05	6.43e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—VEGFA—asthma	1.7e-05	6.43e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—STAT3—asthma	1.68e-05	6.36e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TGFB1—asthma	1.67e-05	6.31e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MMP9—asthma	1.65e-05	6.26e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PTEN—asthma	1.64e-05	6.22e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EGFR—asthma	1.63e-05	6.19e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2—asthma	1.62e-05	6.14e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—asthma	1.61e-05	6.11e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TGFB1—asthma	1.56e-05	5.9e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MMP9—asthma	1.53e-05	5.81e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EGFR—asthma	1.53e-05	5.78e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PTEN—asthma	1.52e-05	5.78e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—VEGFA—asthma	1.48e-05	5.62e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—STAT3—asthma	1.47e-05	5.56e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—VEGFA—asthma	1.38e-05	5.22e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—STAT3—asthma	1.36e-05	5.17e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TGFB1—asthma	1.36e-05	5.16e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EGFR—asthma	1.33e-05	5.06e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TGFB1—asthma	1.26e-05	4.79e-05	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—asthma	1.26e-05	4.76e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EGFR—asthma	1.24e-05	4.7e-05	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—asthma	1.17e-05	4.44e-05	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—asthma	1.03e-05	3.88e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—asthma	9.53e-06	3.61e-05	CbGpPWpGaD
